Yuxin Xu

Suzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Correction: Immunosenescence and metabolic reprogramming in MASLD: an age-dependent immunometabolic vicious cycle and therapeutic opportunities.

Correction: Immunosenescence and metabolic reprogramming in MASLD: an age-dependent immunometabolic vicious cycle and therapeutic opportunities.

Journal: Frontiers in cell and developmental biology
Published: April 07, 2026

Multi-functional intelligent drug-loaded microalgae for the repair of diabetic wounds: oxygen supply, cell proliferation promotion, and hypoglycemic effect.

Multi-functional intelligent drug-loaded microalgae for the repair of diabetic wounds: oxygen supply, cell proliferation promotion, and hypoglycemic effect.

Journal: Biomaterials science
Published: November 10, 2025

Immunosenescence and metabolic reprogramming in MASLD: an age-dependent immunometabolic vicious cycle and therapeutic opportunities.

Immunosenescence and metabolic reprogramming in MASLD: an age-dependent immunometabolic vicious cycle and therapeutic opportunities.

Journal: Frontiers in cell and developmental biology
Published: June 20, 2025

A novel ribociclib derivative WXJ-103 exerts anti-breast cancer effect through CDK4/6.

A novel ribociclib derivative WXJ-103 exerts anti-breast cancer effect through CDK4/6.

Journal: Anti-cancer drugs
Published: February 02, 2023

The atypical ubiquitin ligase RNF31 stabilizes c-Myc via epigenetic inactivation of FBXO32 and promotes cancer development.

The atypical ubiquitin ligase RNF31 stabilizes c-Myc via epigenetic inactivation of FBXO32 and promotes cancer development.

Journal: Cellular signalling
Published: December 15, 2022

Identification of the deubiquitinase USP28 as a novel molecular therapeutic target of ovarian cancer.

Identification of the deubiquitinase USP28 as a novel molecular therapeutic target of ovarian cancer.

Journal: Biochemical and biophysical research communications
Published: November 03, 2022

WXJ-202, a novel Ribociclib derivative, exerts antitumor effects against breast cancer through CDK4/6.

WXJ-202, a novel Ribociclib derivative, exerts antitumor effects against breast cancer through CDK4/6.

Journal: Frontiers in pharmacology
Published: October 17, 2022

VHL-HIF-2α axis-induced SEMA6A upregulation stabilized β-catenin to drive clear cell renal cell carcinoma progression.

VHL-HIF-2α axis-induced SEMA6A upregulation stabilized β-catenin to drive clear cell renal cell carcinoma progression.

Journal: Cell death & disease
Published: September 12, 2022

The USP18-FBXO6 axis maintains the malignancy of ovarian cancer.

The USP18-FBXO6 axis maintains the malignancy of ovarian cancer.

Journal: Biochemical and biophysical research communications
Published: December 27, 2021

SOX9-mediated UGT8 expression promotes glycolysis and maintains the malignancy of non-small cell lung cancer.

SOX9-mediated UGT8 expression promotes glycolysis and maintains the malignancy of non-small cell lung cancer.

Journal: Biochemical and biophysical research communications
Published: October 12, 2021

FBXO2 targets glycosylated SUN2 for ubiquitination and degradation to promote ovarian cancer development.

FBXO2 targets glycosylated SUN2 for ubiquitination and degradation to promote ovarian cancer development.

Journal: Cell death & disease
Published: September 19, 2021
Showing 1-11 of 11

Last Updated: 09/26/2026